Methylphenidate-associated chest pain in a child.

Autor:	Masiran R; Department of Psychiatry, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia ruziana_m@upm.edu.my.; Department of Psychiatry, Hospital Sultan Abdul Aziz Shah, Serdang, Selangor, Malaysia., Ilias MNA; Department of Psychiatry, Hospital Sultan Abdul Aziz Shah, Serdang, Selangor, Malaysia., Yubbu P; Department of Psychiatry, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.; Pediatric Cardiology Unit, Hospital Serdang, Serdang, Selangor, Malaysia.
Jazyk:	angličtina
Zdroj:	BMJ case reports [BMJ Case Rep] 2023 Nov 27; Vol. 16 (11). Date of Electronic Publication: 2023 Nov 27.
DOI:	10.1136/bcr-2023-255187
Abstrakt:	A young child was diagnosed with autism spectrum disorder with comorbid attention-deficit/hyperactivity disorder. His hyperactivity, impulsivity and absence of awareness towards danger increased his risk of harm and hence methylphenidate was indicated. Unfortunately, he developed chest pain eight months after the treatment initiation. We then stopped the stimulant and changed his treatment to atomoxetine, after which he no longer had chest pain. In the following illustrated case, we will discuss the cardiac side effect of methylphenidate. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu